PCG
ABBV icon

Private Capital Group’s AbbVie ABBV Stock Holding History

Private Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$524K Sell
3,423
-128
-4% -$19.6K 0.39% 41
2022
Q1 		$576K Buy
3,551
+183
+5% +$26.6K 0.13% 98
2021
Q4 		$456K Sell
3,368
-122
-3% -$14.4K 0.1% 132
2021
Q3 		$377K Sell
3,490
-8
-0.2% -$914 0.08% 151
2021
Q2 		$394K Sell
3,498
-71
-2% -$8K 0.09% 143
2021
Q1 		$386K Sell
3,569
-2,717
-43% -$291K 0.1% 128
2020
Q4 		$674K Sell
6,286
-664
-10% -$63.8K 0.12% 123
2020
Q3 		$609K Buy
6,950
+607
+10% +$57.1K 0.13% 128
2020
Q2 		$623K Buy
6,343
+346
+6% +$30.5K 0.13% 116
2020
Q1 		$457K Buy
5,997
+1,605
+37% +$137K 0.12% 128
2019
Q4 		$388K Sell
4,392
-2,560
-37% -$213K 0.08% 152
2019
Q3 		$526K Buy
6,952
+405
+6% +$27.8K 0.09% 136
2019
Q2 		$607K Sell
6,547
-404
-6% -$31.8K 0.14% 108
2019
Q1 		$560K Buy
6,951
+451
+7% +$36.9K 0.11% 126
2018
Q4 		$599K Sell
6,500
-750
-10% -$66K 0.13% 113
2018
Q3 		$685K Sell
7,250
-923
-11% -$87.5K 0.14% 113
2018
Q2 		$757K Buy
8,173
+118
+1% +$11.5K 0.16% 101
2018
Q1 		$762K Buy
8,055
+7,186
+827% +$789K 0.17% 99
2017
Q4 		$760 Buy
+869
New +$81.9K 0.18% 91

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Private Capital Group's ABBV Position: Q2 2022 in Review

Private Capital Group reduced its AbbVie (ABBV) stake by 3.6% in Q2 2022, selling an estimated $19.6K and leaving 3,423 shares worth $524K. The position accounts for 0.39% of the portfolio, ranked #41.

Private Capital Group first reported a position in ABBV in Q4 2017 and has held it in 19 quarters since. The position peaked at $762K in Q1 2018. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

  • Private Capital Group held 3,423 shares of AbbVie worth $524K as of Q2 2022.
  • Private Capital Group sold 128 AbbVie shares in Q2 2022, an estimated $19.6K.
  • AbbVie made up 0.39% of Private Capital Group's portfolio in Q2 2022, its #41 holding.
  • Private Capital Group first reported a position in AbbVie in Q4 2017 and has held it in 19 quarters since.
  • Private Capital Group's AbbVie position peaked at $762K in Q1 2018.
  • 3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.